| Byrd, K. M., Huang, N., & Perez, P. (2020). Integrated Single-Cell Atlases Reveal an Oral SARS-CoV-2 Infection and Transmission Axis. medRxiv, 2020.10.26.20219089. |
 
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 21/10/2023, 17:47 |
|
| Daniels, S., Wei, H., & Denning, D. W. (2021). Platelet size as a predictor for severity and mortality in COVID-19 patients: a systematic review and meta-analysis. medRxiv, 2021.07.15.21260576. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 23/07/2021, 08:42 |
|
| Koch, C. M., Prigge, A. D., Anekalla, K. R., & others. (2021). Immune response to sars-cov-2 in the nasal mucosa in children and adults. medRxiv. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 17/06/2021, 18:15 |
|
| Ramos da Silva, S., Ju, E., Meng, W., Paniz Mondolfi, A. E., Dacic, S., & Green, A., et al. (2020). Broad SARS-CoV-2 cell tropism and immunopathology in lung tissues from fatal COVID-19. medRxiv, 2020.09.25.20195818. |
|
| Added by: Dr. Enrique Feoli 01/10/2020, 10:56 |
|
| Seow, J., Graham, C., Merrick, B., Acors, S., Steel, K. J. A., & Hemmings, O., et al. (2020). Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection. medRxiv, 2020.07.09.20148429. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 14/07/2020, 19:14 |
|
| Tan, J., Anderson, D. E., Rathore, A. P. S., & others. (2021). Signatures of mast cell activation are associated with severe covid-19. medRxiv, 2021.05.31.21255594. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 05/06/2021, 10:15 |
|
| Varadhachary, A., Chatterjee, D., Garza, J., Garr, R. P., Foley, C., & Letkeman, A. F., et al. (2020). Salivary anti-SARS-CoV-2 IgA as an accessible biomarker of mucosal immunity against COVID-19. medRxiv, 2020.08.07.20170258. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 03/10/2020, 13:56 |
|
| Woodruff, M., Ramonell, R., Cashman, K., Nguyen, D., Saini, A., & Haddad, N., et al. (2020). Dominant extrafollicular B cell responses in severe COVID-19 disease correlate with robust viral-specific antibody production but poor clinical outcomes. medRxiv, 2020.04.29.20083717. |
|
| Added by: Dr. Enrique Feoli Last edited by: Dr. Enrique Feoli 03/10/2020, 14:03 |
|
| Wu, F., Wang, A., Liu, M., Wang, Q., Chen, J., & Xia, S., et al. (2020). Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. medRxiv, 2020.03.30.20047365. |
|
| Added by: Dr. Enrique Feoli 15/07/2020, 10:52 |
|
